OrganoTherapeutics – Sale to Transpharmation

  • Member TENZING Partners
  • Sector Life Sciences
  • Date completed 23.10.2026
  • Client OrganoTherapeutics
  • Country Luxembourg
  • Acquirer Transpharmation Ltd.
  • Country Canada

Tenzing Partners acted as exclusive sell-side M&A advisor to the shareholders of OrganoTherapeutics SARL on its sale to Transpharmation, a UK/Canada-based preclinical contract research organisation (CRO) specialised in neuroscience.

The acquisition allows Transpharmation to add human-relevant in vitro organoid models to its in vivo neuroscience pharmacology capabilities, offering drug developers both approaches through a single partner. OrganoTherapeutics continues to operate as a subsidiary of Transpharmation.

Tenzing advised the founders throughout the process, adding a new cross-border transaction to its track record: Luxembourg seller, UK/Canada buyer.

TENZING Partners
Sold to

Get Started

Find out how the Globalscope family can help you realise your business dreams.